Tarik Catic1, Josip Culig2, Enra Suljic3, Admir Masic3, Refet Gojak3. 1. Society for Pharmacoeconomics and Outcomes Research in Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina. 2. Andrija Stampar" School of Public Health, Zagreb, Croatia. 3. University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.
Abstract
INTRODUCTION: The purpose of this study was to validate Bosnian translation of disease specific quality of life measure MSQoL-54 which is widely used in practice. MATERIAL AND METHODS: Previously translated and culturally adopted MSQoL-54 questionnaire used in this study has been provided and licensed by Optum Inc. The questionnaire was validated in 62 MS patients seen at Neurology clinic at University Clinical Center Sarajevo, during April 2016 until May 2016. Internal reliabilities of Bosnian version MSQoL-54 were assessed for multiple item scales by using Cronbach's alpha coefficient. Clinical validity was assessed comparing means of the two summary MSQoL-54 scores by the EDSS score. Pearson's (r) correlation coefficient was used to investigate the relationship between the composite scores and the main clinical and demographic variables. RESULTS: Patients' participation was satisfactory and all scales fulfilled the usual psychometric standards. Highly significant inverse relationship was found between both composite scores and clinical characteristics of the disease and the EDSS. The lowest internal consistency reliability is found on social function scale (0.743), overall quality of life (0.782) and pain (0.833). The highest internal consistency reliability is found on role limitations due to physical problems (0.959), physical health (0.962) and role limitations due to emotional problems (0.966). The mean value of MSQoL-54 PHC (Physical Health Composite) and MHC (Mental Health Composite) were 49.82±18.90 (36.05-61.38) 51.84±22.22 (34.93-70.20) respectively. Our study has shown that the Bosnian version of MSQoL-54 is easy to administer and well accepted by patients and may be useful as clinical outcome measures in patients with MS.
INTRODUCTION: The purpose of this study was to validate Bosnian translation of disease specific quality of life measure MSQoL-54 which is widely used in practice. MATERIAL AND METHODS: Previously translated and culturally adopted MSQoL-54 questionnaire used in this study has been provided and licensed by Optum Inc. The questionnaire was validated in 62 MSpatients seen at Neurology clinic at University Clinical Center Sarajevo, during April 2016 until May 2016. Internal reliabilities of Bosnian version MSQoL-54 were assessed for multiple item scales by using Cronbach's alpha coefficient. Clinical validity was assessed comparing means of the two summary MSQoL-54 scores by the EDSS score. Pearson's (r) correlation coefficient was used to investigate the relationship between the composite scores and the main clinical and demographic variables. RESULTS:Patients' participation was satisfactory and all scales fulfilled the usual psychometric standards. Highly significant inverse relationship was found between both composite scores and clinical characteristics of the disease and the EDSS. The lowest internal consistency reliability is found on social function scale (0.743), overall quality of life (0.782) and pain (0.833). The highest internal consistency reliability is found on role limitations due to physical problems (0.959), physical health (0.962) and role limitations due to emotional problems (0.966). The mean value of MSQoL-54 PHC (Physical Health Composite) and MHC (Mental Health Composite) were 49.82±18.90 (36.05-61.38) 51.84±22.22 (34.93-70.20) respectively. Our study has shown that the Bosnian version of MSQoL-54 is easy to administer and well accepted by patients and may be useful as clinical outcome measures in patients with MS.
Entities:
Keywords:
Bosnian; MSQoL-54; Multiple sclerosis; Quality of life; Validation
Multiple sclerosis (MS) is progressive, autoimmune neurodegenerative disorder, causing damage of the central nervous system (CNS) as a result of myelin sheath damage. Impact of nervous system results on impact on many other body systems and body as whole gradually as disease progress.The disease mainly affects young adults; more often women (1). According to some studies, 70% of patients with multiple sclerosis are between 15 and 45 years of age (2). The prevalence of multiple sclerosis varies regionally, and is the largest in the countries of Northern Europe, Australia and the United States of America (3). It is estimated, based on data from clinics health insurance funds than MS affects more than 3.000 patients in Bosnia and Herzegovina (4). Kingwell et all published a study in 2013 stating that the incidence of MS in Bosnia and Herzegovina is 1.6/100.000 (5). MS significantly impact patients’ quality of life. Health related quality of life is often used as an outcome measurement in pharmacoeconomic evaluation of medicines which is used as tool for health care policy decision making tool. One of the most wide used disease specific instrument for measuring health related quality of life (HRQOL) in MS is the Multiple Sclerosis Quality of Life 54 (MSQoL-54). This instrument was developed in USA (6) and now it is available in different languages, with translation and cultural adaptation (7-11). Bosnian translation of MSQoL 54 is available and it was used in some studies and research projects in Bosnia and Herzegovina (12).The 54 items of this questionnaire is distributed into 12 multi-item scales and 2 single items. Two summary scores physical health composite (PHC) and mental health composite (MHC) can be derived from a weighted combination of scale scores.The aim of this study was to assess validity of Bosnian translation of MSQoL-54 in population of 62 MSpatients diagnosed MS according to well established diagnostic criteria (13).
2. METHODS AND MATERIALS
Sixty patients diagnosed with MS participated in this study, all admitted at Neurology clinic at University Clinical Center Sarajevo, during April 2016 until May 2016. Inclusion criteria were that they are older than 18 years, have diagnosed relapsing remitting MS according to McDonald’s criteria and written informed consent. Exclusion criteria were an exacerbation in the last month, pre-existing other chronic illness and/or psychiatric disorders. Out of 95 patients seen in this period 65 met inclusion criteria, and 62 submit properly filled questionnaires, which has been taken into analysis. In this study we used MSQoL-54 already translated and culturally adopted into Bosnian language. Translated questionnaire has been provided and licensed by Optum Inc.The MSQoL-54 questionnaire was filled in by the patients with presence of physician who could assist in of eventual problems in understanding questions and technical way of filling the questionnaire. Patient disability has been assessed by the neurologist using the Expanded Disability Status Scale (EDSS) score (14).MSQoL-54 scale scores were created using the Likert method by averaging items within the scales and, then row scores were linearly transformed into 0–100 scales. Higher values indicate better quality of life. Assessment of patients` acceptability of MSQoL-54 was performed by noting the mean time required for completing the questionnaire and assistance in reading and/or writing. Missing data has been avoided because presenting physician supervised the process.Internal reliabilities of Bosnian version MSQoL-54 were assessed for multiple item scales by using Cronbach’s alpha coefficient (15), ranges from 0–1, where 1 means perfect reliability.Clinical validity was assessed comparing means of the two summary MSQoL-54 scores by the EDSS score.Pearson’s (r) correlation coefficient was used to investigate the relationship between the composite scores and the main clinical and demographic variables. Statistical analysis is done using SPSS v 16.0 software.
3. RESULTS
Demographic and clinical characteristics of patients enrolled in the study are presented in Table 1, including type of treatment receiving at the moment of filing the questionnaire. All patients were diagnosed as relapsing remitting multiple sclerosis and 33 are treated with immunomodulatory therapy (53.2%), steroid pulse therapy is applied at 20 (32.3%) patients while 9 (14.5%) patients are not treated at the moment of study conduction.
Table 1
Demographic and clinical characteristics of patients with multiple sclerosis
Demographic and clinical characteristics of patients with multiple sclerosisAll patients clearly comprehend questionnaire. Average time to complete the questionnaire was 14 minutes, ranging from 4 to 20 minutes. Six (10%) patients needed help; four (6%) needed help in reading and 3 (5%) required writing help.The mean scale scores and internal consistency (Cronbach’s alpha) are presented in Table 2.
Table 2
Descriptive statistics and reliability for the Bosnian version MSQoL-54
Descriptive statistics and reliability for the Bosnian version MSQoL-54The lowest means are recorded for disabilities due to physical problems (14.92 ± 32.79), disabilities due to emotional problems (23.66 ± 41.55) and cognitive function (36.21 ± 13.78). The highest mean values are recorded at emotional well-being (65.35 ± 19.20), satisfaction in sexual function (68.44 ± 35.62) and sexual function (70.99 ± 33.68). Internal consistency reliability for these scales ranged from 0.743 on social function to 0.966 on role limitations due to emotional problems. The lowest internal consistency reliability is found on social function scale (0.743), overall quality of life (0.782) and pain (0.833). The highest internal consistency reliability is found on role limitations due to physical problems (0.959), physical health (0.962) and role limitations due to emotional problems (0.966).The mean value of MSQoL-54 PHC (Physical Health Composite) and MHC (Mental Health Composite) were 49.82 ± 18.90 (36.05-61.38) 51.84 ± 22.22 (34.93-70.20) respectively as presented in Table 3.
Table 3
Descriptive statistics MSQOL-54 Composite Score
Descriptive statistics MSQOL-54 Composite ScoreBoth MSQoL-54 composite scores showed strong correlation with the EDSS (r = –0.765; P = 0.0001) for PHC, and r = –0.584; P= 0.0001 for MHC) as shown in Table 4.
Table 4
Clinical validity: Correlation of MSQOL-54 Composite Score with EDSS
Clinical validity: Correlation of MSQOL-54 Composite Score with EDSSStatistically significant inverse (negative) correlations were found between EDSS score and all scales of MSQoL-54 (Table 5).
Table 5
Clinical validity: Correlation of Bosnian version MSQoL-54 with EDSS
Clinical validity: Correlation of Bosnian version MSQoL-54 with EDSSThe most significant correlations are found between EDSS score and pain (r = -0.689, p<0.0001), social function (r = -0.695, p<0.0001) and physical health (r = -0.841, p<0.0001). The lowest negative correlation is found on role limitations due to physical problems (r = -0.294, p<0.020), role limitations due to emotional problems (r = -0.327, p < 0.010) and health distress (r = -0.470, p < 0.0001).Comparison of our results with the data from the original American study and validation studies from Hungary and Italy between the mean scale scores of the patients groups is presented in Figure 1.
Figure 1
Comparison of median scale scores of the American, Hungarian, Italian and Bosnian multiple sclerosis patient sample. PH=Physical Health; RP=Role limitations–physical; RE=Role limitations–emotional; PN=Pain; EB=Emotional well-being; EN=Energy; HP=Health Perceptions; SF=Social function; CF=Cognitive function; HD=Health distress; SX=Sexual function; CH=Change in health; SS=Satisfaction in sexual function; OQ=Overall quality of life
Comparison of median scale scores of the American, Hungarian, Italian and Bosnian multiple sclerosispatient sample. PH=Physical Health; RP=Role limitations–physical; RE=Role limitations–emotional; PN=Pain; EB=Emotional well-being; EN=Energy; HP=Health Perceptions; SF=Social function; CF=Cognitive function; HD=Health distress; SX=Sexual function; CH=Change in health; SS=Satisfaction in sexual function; OQ=Overall quality of life
4. DISCUSSION
The Bosnian MSQOL-54 questionnaire was easy to administer and well accepted by our MSpatients, with 95% of them stating that no embarrassing or difficult to interpret questions were present. This result is not different from those obtained from American (US), Italian, Turkish and Serbian MSpatients (6, 7, 9, 11). Small percentage of patients needed help and assistance from physician to complete questionnaire. For small number of patients (5%) questions related to sexual function and satisfaction with sexual function caused inconvenience. In previously published similar studies these questions were main source of missing data (11, 16). Missing data in our study are avoided due to additional explanations and support by presenting physician. It is also noted that these questions are more embarrassing to females than males which could be result of cultural reasons. Solari at al proposed adding an additional response ‘not applicable’ to one sexual function item and to the sexual satisfaction item in order to reduce rate on missing data (17).Average time to complete questionnaire was 14 minutes, ranging from 4 to 20 minutes which means that it was not a difficult task for the patients and that questionnaire was easy to understand. Similar results are found in other studies where average time to complete the MSQOL- 54 ranged between 11.8-30 minutes (7, 18, 19).In our MSpatients, we found that internal consistency reliability for these scales ranged from 0.743 on social function to 0.966 on role limitations due to emotional problems. MSQoL-54 scales were reliable in the Bosnia and Herzegovina population as elsewhere (11, 20).EDSS scores in our study correlated significantly negatively with all MSQoL-54 health dimensions. These correlations are similar to previously conducted validation studies. PHC and MHC also showed significant correlation with EDSS. Serbian validation study found that these domains significantly correlated with patients’ age, education and employment status. Hungarian validation study reported that the patient group having lower EDSS score had better HRQOL scores on each scale. Solari et al also found high correlation between both composite scores and age. Other factors can also influence quality of life of MSpatients. In Hungary validation study showed that. Younger patients with a higher level of education, shorter duration of the disease and a first attack or benign clinical form of the disease had a better quality of life. Previous studies showed that unemployed patients reported low scores in some HRQoL domains, such as physical role limitation, physical function, and emotional limitation (21). Also, education seems to have some impact on HRQoL where high school or college graduates had higher physical health composite scores than patients with a low educational level (22). Study conducted in Bosnia and Herzegovina showed that sustained employment and development of vocational rehabilitation programs for MSpatients living in the country with high unemployment level is an important factor in improving both physical and mental health outcomes in MSpatients (23).
5. CONCLUSIONS
Our study has shown that the Bosnian version of MSQoL-54 is easy to administer and well accepted by patients. Its internal consistency reliability measured by Cronbach alpha coefficient is well above the minimum requirement in case of all scales. Use of this instrument in routine practice could provide additional information about treatment outcomes related to patients` quality of life to the physicians.
Authors: J Füvesi; K Bencsik; K Benedek; K Mátyás; E Mészáros; C Rajda; E Losonczi; Zs Fricska-Nagy; L Vécsei Journal: Mult Scler Date: 2008-01-21 Impact factor: 6.312
Authors: Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie Journal: BMC Neurol Date: 2013-09-26 Impact factor: 2.474
Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422
Authors: Teng I Leong; Tracey J Weiland; George A Jelinek; Steve Simpson; Chelsea R Brown; Sandra L Neate; Keryn L Taylor; Emily O'Kearney; Elasma Milanzi; Alysha M De Livera Journal: Front Neurol Date: 2018-11-02 Impact factor: 4.003